Loading company…
Oxford-based biopharmaceutical company developing antigen-specific immunotherapies for chronic infectious diseases and cancer.
Oxxon Therapeutics Ltd is a biopharmaceutical company based in Oxford, UK. It develops antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer. The stage is listed as Series A.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in